Stock Groups

U.S. administers 429.4 million doses of COVID-19 vaccines –CDC -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – A healthcare worker prepares a syringe containing Moderna COVID-19 Vaccine, at a Pop-up Vaccination Site operated by SOMOS community Care, New York City, New York. The event took place during the COVID-19 Pandemic, New York City. January 29, 2021. REUTERS/Mike

(Reuters) – The United States had administered 429.442,508 COVID-19 doses to the nation as of Saturday morning and distributed 533,019,545 doses.

These numbers are higher than the 428,006,540 doses of vaccine administered Nov. 4, from 531,287.645 doses, according to the CDC.

It stated that 223,245,121 persons had been given at least one dose of vaccines, and that 193,627.929 individuals were completely vaccinated as per the agency’s records. This was in addition to 2234,5121 who received at most one dose. ET Saturday

Two-dose vaccinations are included in the CDC tally Moderna (NASDAQ:) and Pfizer/BioNTech,, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

A booster dose has been given to approximately 23.2 million people. Pfizer (NYSE:), Moderna or Johnson & Johnson’s COVID-19 vaccine.

Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]